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utility	 of	 fluorescent	 bioconjugations	 in	 developing	 a	 noninvasive	 screen	 for	 prostate	 cancer.	
Finally,	 the	 unique	 radical	 pathway	 of	 a	 multifunctional	 globin,	 dehaloperoxidase,	 will	 be	
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Proteins are often called the building blocks of life, comprising the molecular machinery 
that carries out countless different functions, from catalyzing reactions, to forming channels for 
ions to flow through in response to a ligand. These myriad applications are the result of what is 
known as the structure-function relationship, where the three-dimensional structure and chemical 
nature of a protein determines its role in the cell.1 These relationships could be as complex the 
shape, electrical charge, and hydrophobicity of a binding site determining precisely what ligands 
an enzyme targets, or it could be as simple as the size of a channel’s pore only allowing tiny sodium 
ions to pass through. As one might imagine, these structures can be immensely complex, yet they 
form almost instantaneously as a protein is translated; so fast that 
conventional methods are not able to observe the process.2 This 
is thanks to the intermolecular forces that govern the three levels 
of structure that are generated in the production of a single 
protein. The order of the assembled chain of amino acids is 
known as the primary structure. The sterics and interactions 
caused by the individual amino acid’s R groups (such as the turns 
of Proline residues) and hydrogen bonding between areas of the 
back chain give rise to the α-helices, β-sheets, and β-turns that 
constitute a protein’s secondary structure.3 Further hydrogen 
bonds, dipole-dipole interactions, and disulfide bonds between 
these structures then form the tertiary structure that determines 
the greater shape of the protein.3 Figure	1.1:	Three	phases	of	protein	
folding1 
	 7	
The ability for a protein to fold, and therefore function, is 
ultimately reliant on its primary structure--the specific sequence of 
amino acids that are translated. Each individual amino acid is 
comprised of an α-carbon surrounded an amine and carboxyl group 
that make up the aforementioned back chain, a hydrogen, and a 
variable “R” group. There are twenty proteinogenic amino acids, and therefore twenty different R 
groups that confer different properties to a protein, from acidic groups affecting its pKa to nonpolar 
groups causing entire sections of a protein to be sequestered away. Each individual amino acid is 
shuttled to a ribosome via a paired tRNA molecule, where condensation reactions form the 
growing polypeptide. Each tRNA recognizes one specific mRNA codon and carries the 
corresponding amino acid, which are paired together utilizing enzymes called aminoacyl-tRNA 
synthetases (aaRS). For each of the twenty natural amino acids, there are twenty aaRSs, most of 








same amino acid.4 Codons are three nucleotide-long segments of mRNA that signal the ribosome-
tRNA complex to either deposit another amino acid onto the polypeptide or signal the termination 
of its synthesis. 
Escherichia coli are used to produce a large amount of a select protein in a laboratory 
setting by taking advantage of the central dogma of molecular biology. The central dogma of 
molecular biology states that all proteins are created from DNA in what can be reduced down to a 
two step process: the transcription of mRNA from a gene followed by its translation into a protein.5 
As a bacteria, E. coli’s DNA is in the form of a plasmid: a simple, uncondensed loop of genetic 
information. Researchers are able to 
use a variety of methods, including 
heat and electrical shock, to 
incorporate foreign DNA into these 
cells via a process called 
transformation.6 Each foreign 
plasmid will contain its own 
antibiotic resistance gene in addition 
to the protein of interest, allowing 
researchers to create conditions 






acids (UAAs) are amino 
acids that are not a part of 
the aforementioned 
proteinogenic twenty, 
and can either be found 
naturally or synthesized.7 




incorporating UAAs in to 
proteins--a concept that allows researchers to engineer additional functionalities into natural 
proteins. This is done via a process of amber suppression, in which the uncommon amber stop 
codon (TAG) is used to replace the codon at the site of the natural amino acid.8 A tRNA/aaRS pair 
is developed that recognizes the TAG codon and UAA, working in tandem to incorporate the UAA 
into a cell’s normal translational process.8 Mutant aaRSs are created by subjecting four tyrosine 
binding sites of a natural aaRS to random amino acids via mutagenic PCR.9 The library of mutant 
aaRS plasmids are then co-transformed with a gene that provides chloramphenicol (chlor) 
resistance into E. coli via electroporation. The gene that provides chlor resistance also has an amber 
stop codon in the place of a tyrosine residue, meaning that without the successful function of the 
synthetase the cell will not be able to read through the TAG codon or possess the resistance. The 




chlor and the UAA of interest. Cells that survive this process are then known to possess the mutant 
aaRS, but it is unknown whether it is selectively inserting the UAA or a natural tyrosine at the 
amber stop codon.9 This is why cells then go through a negative selection process, in which the 
positively selected for aaRSs are then co-transformed into new cells with a gene for barnase, a 
cytotoxin.9 This gene contains three TAG codons, and the cells are grown in the absence of any 
UAA. Therefore, if any aaRS is able to incorporate natural amino acid at a TAG codon, barnase is 
produced and the cells die, but if only the UAA is recognized, it is not present and no barnase is 
produced. This entire process of positive and negative selection, known as a double sieve selection 
process (Figure 1.8) is repeated several times in order to obtain a highly selective synthetase.8,9 In 
order to evolve the corresponding bioorthogonal tRNA, a selected codon is mutated to respond to 
the amber stop codon, thereby suppressing it. To further improve the mutant tRNA’s orthogonality, 
eleven nucleotides were mutated as “negative recognition determinants”10  that ensure the mutant 
tRNA cannot bind to a natural aaRS. Cells expressing these tRNAs were then put through rounds 
of negative selection 
followed by positive 
selection in a process 
akin to the aaRS 
selection.10 What 
results is a 
tRNA/aaRS pair that 
is specific to a UAA 
while also being 
highly orthogonal to Figure	1.8:	The	double	sieve	selection	process.9 
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any native translational machinery, ensuring that any protein synthesized containing the amber 
stop codon will contain the selected UAA.  
In order to create the protein of interest with the selected UAA, a double transformation 
into E. coli is used in order to introduce the gene for a protein containing the TAG mutation and 
the gene for the mutant tRNA/aaRS pair. Typically, the protein gene contains a promoter for 
isopropyl β-D-1-thiogalactopyranoside (ITPG) and ampicillin (amp) resistance built in, and the 
tRNA/aaRS pair contains an arabinose promoter and chlor resistance built in.10 Similar to the 
positive selection process of tRNA/aaRS mutagenesis, the antibiotic resistances ensure that both 
plasmids are incorporated to the E. coli. Cell cultures are grown in the presence of all relevant 
antibiotics, IPTG, arabinose, and the UAA of choice, whereupon the tRNAs are able to incorporate 
the UAA site-specifically to the amber stop codon, allowing massive mutant protein yields.10,11 
UAA incorporation opens the door to a novel methodology of exploring the structure-function 
relationship in proteins and allows proteins to exhibit new and 
exciting functionalities, such as their participation in 
bioconjugations.  
Bioconjugations 
A bioconjugation is any reaction linking DNA, 
protein, or any other biological macromolecule to a secondary 
molecule. These secondary molecules can be a vast array of 
organic or inorganic candidates: from fluorophores or 
radioactive labels useful for imaging, to a solid support for 
immobilizing purposes, to another macromolecule.12 While it 
is possible to utilize the twenty proteinogenic amino acids in Figure	1.9:	Schultz	method	of	expressing	
protein	with	UAAs.15	
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bioconjugations, it is not ideal for several reasons. The most straightforward of these reasons is 
the extreme bottleneck researchers would face if they were forced to devise conjugative reactions 
that only utilize specific functional groups of the twenty natural amino acids. Another more 
prohibitive reason against the use of the naturally proteinogenic amino acids is the lack of bio-
orthogonality that any chemical reaction used would be subject to. In other words, there would be 
no selectivity in only targeting the protein of interest, much less targeting a specific site within that 
protein. As a result, bioconjugations utilizing  site-specific UAAs are extremely useful in 
overcoming these hurdles. 
This thesis employs two bioconjugative reactions to varying levels of success. The first of 
these is the CuAAC “click” reaction, which is the linking of an azide with an alkyne, yielding 1,4-
linked 1,2,3-triazoles (figure 1.7).13 This reaction takes advantage of a Cu(I) catalyst that allows it 
to proceed without the addition of excess heat which could potentially denature the protein of 
interest.14 Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) is used as  a coordinating 




protein.15 Finally, the addition of TCEP as a reducing agent prevents the oxidation of Cu(I), which 
would interfere with its catalytic abilities. The reaction proceeds as shown in schematic 1.2, and 
can be used in conjunction with para-Azidophenylalanine (pAzF) para-propargyloxyphenylalanine 
(pPrF) UAAs. Researchers have used this reaction in a number of ways, such as coupling terminal 
alkynes with aryl, alkyl, and sulfonyl azides, and utilizing immobilized Cu(I) to catalyze the 
reaction of terminal alkynes with sodium azide benzyl and alkyl halides to produce 1,4-
disubstituted 1,2,3-triazoles.16,17 
The second bioconjugative reaction used is the Glaser-Hay coupling, which links two 
terminal alkynes as seen in figure 1.8. Just like the CuAAC reaction, this is a bioorthogonal 
addition as there are no naturally occurring alkynes, 
allowing for very high specificity. Glaser discovered 
that coupling of two terminal alkynes could occur 
when exposed to a Cu(I) intermediate and air.18 Hay 
then modified the reaction with the finding that the 
addition of N,N,N′,N′-tetramethylethylenediamine 
(TMEDA) stabilizing the reaction in much the same 
way TCEP does for the CuAAC reaction.18 While 
Glaser and Hay made these findings in 1869 and 1962 
respectively, it was not until 2015 that Lampkowski 
determined its optimal biological conditions--running 
for six hours at 4 oC.18,19 This reaction is able to 
conjugate fluorophores or other biomolecules to p-
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deprotonation	 leading	 to	 a	
stronger	 emission	 at	 512	 nm.8	
This	 finding	 prompted	 the	
investigation	 towards	 GFP’s	
possibility	 as	 a	 natural	
physiological	pH	sensor.		
	
Figure	2.1:	 (A)	Structure	of	3-F1Y,	3,5-F2Y,	2,3-F2Y,	2,3,5-F3Y,	and	2,3,6-F3Y,	 respectively.	 (B)	Crystal	 structure	of	GFP.	 	β-barrel	
structure	in	green	surrounding	chromophore	in	red.	(C)	Chemical	structure	of	fluorophore	located	at	Tyr-66	
Unnatural	 amino	 acids	 (UAAs)	 can	 be	 utilized	 to	 expand	 the	 functionality	 of	 GFP.	 By	
replacing	 the	 tyrosine	with	an	UAA,	 the	pKa	of	 the	phenolic	proton	can	be	 fine-tuned.10	This	
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replacement	 can	 be	 done	 at	 precisely	 residue	 66	 in	 vivo	 using	 the	 Shultz	 site-specific	 UAA	
incorporation	methodology,	which	has	been	utilized	with	over	100	unique	UAAs	in	a	variety	of	










steric	 interactions.	 A	 benefit	 of	 fluorotyrosines	 in	 particular	 is	 the	 ability	 to	 place	 additional	
fluorines	in	the	tyrosine	core,	dramatically	increasing	the	residue’s	electronegativity	with	each	
consecutive	 fluorine.	 Previous	 attempts	 at	 incorporating	 fluorotyrosines	 into	 GFP	 involved	









photophysical	 and	 physiological	 sensing	 properties	 of	 these	 mutant	 GFPs	 in	 the	 hopes	 of	
developing	novel	fluorescent	protein	biosensors.		


















thiogalactopyranoside	 (IPTG)	 and	 arabinose	 to	 begin	 the	 production	 of	 GFP	 both	 with	 and	
without	the	addition	of	variant	fluorotyrosines.	The	five	fluorotyrosine	variations	utilized	were	3-
fluorotyrosine	 (3-F1Y),	 3,5-difluorotyrosine	 (3,5-F2Y),	 2,3-difluorotyrosine	 (2,3-F2Y),	 2,3,5-


















mutant	 at	 a	 λmax	 of	 465	 nm	 (Figure	 3).	 This	 property	 is	 the	 result	 of	 the	 stabilization	 of	 the	
fluorophore	HOMO	due	to	the	electron-withdrawing	nature	of	the	fluorines,	leading	to	a	steeper	
energy	 requirement	 for	 electronic	 transitions.	 These	 unique	 fluorophores	 required	 spectral	
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characterization	to	better	understand	the	effect	of	the	fluorine	substituents.	Using	this	data,	the	
extinction	 coefficient	 was	 calculated	 by	 using	 a	 nanodrop	 to	 measure	 the	 concentration	 of	




for	 the	 calculation	 of	 the	 extinction	 coefficient	 of	 each	 fluorophore—the	 measure	 of	 how	
strongly	 a	 chemical	 substance	 absorbs	 light.	
After	 the	 absorbance	 has	 been	 determined,	
fluorescent	emission	spectra	was	measured	by	
exciting	 the	 proteins	 at	 their	 previously	
recorded	 λmax’s.	 The	 largest	 emission	 shift	
compared	to	wild-type	GFP	is	again	the	2,3,6-

















GFP λmax,abs (nm) ε  (cm−1 M−1) λmax,em (nm) 
Y 483 61,700 507 
3,5-F2Y 478 31,400 511 
2,3-F2Y 473 27,000 506 
2,3,5-F3Y 478 59,900 512 
2,3,6-F3Y 465 26,800 491 
Table	2.2:	Spectral	properties	of	WT-GFP	and	mutants	



















General:	All	GFP	used	 in	 this	 study	was	purified	with	a	Qiagen	Ni-NTA	Quik	Spin	Kit	 (Qiagen,	


















purity	 is	 then	 determined	 via	 SDS-PAGE	 and	 a	 Nanodrop	 spectrophotometer	 (ThermoFisher,	
Pittsburgh,	PA,	USA).	







	 The	 extinction	 coefficient	 of	 all	 samples	 were	 characterized	 by	 utilizing	 a	
spectrophotometer	to	measure	the	absorbance	and	concentration	of	all	samples	in	μg/mL,	which	
was	then	converted	to	mM	using	dimensional	analysis.	Dilutions	of	1:1,	2:1,	and	10:1	amounts	of	









as	 a	 biosensor.	Moreover,	 this	 study	 demonstrates	 that	mild	 structural	 changes,	 such	 as	 the	






























































	 Prostate	cancer	 is	one	of	the	most	common	forms	of	cancer	 in	humans,	and	the	most	
common	form	in	men	with	about	30%	more	incidents	reported	in	2018	than	the	next	highest	
type	of	cancer.1	Unfortunately,	the	most	common	initial	method	of	diagnosis	is	testing	the	blood	
for	 increased	 levels	 prostate-specific	 antigen	 (PSA).	 This	method	 rnonspecific	 and	 oftentimes	
leads	to	false	positives,	as	there	are	a	number	of	other	conditions	that	can	affect	PSA	levels.2	This	
means	 that	 follow-up	biopsies	are	often	 required	 to	confirm	a	diagnosis,	with	many	of	 those	


























order	 to	 reach	 the	 catalytic	 active	 site	 that	 ensures	 selectivity	 for	 SUMO.9	 The	 non-catalytic	

















	 Previous	work	 on	 this	 project	 created	 a	 number	 of	mutant	Utag	 proteins	 using	Quik-
Change	PCR	site	directed	mutagenesis	and	Q5	PCR.	Sites	chosen	were	surface-exposed	tyrosine	
residues,	 as	 their	 replacement	 with	 the	 chosen	 UAAs	 would	 result	 in	 minimal	 structural	
perturbations	 in	 addition	 to	 providing	 ease	 of	 access	 in	 subsequent	 bioconjugations.	 Several	





successful	 Glaser-Hay	 reactions,	 with	 the	 SDS-PAGE	 demonstrating	 fluorescent	 bands	 at	 the	















truncation.	 Simply	 put,	 it	 is	 an	 issupressing	 yeast	 proteins	 in	 E.	 coli	 cells.	 Codon	 bias	 is	 the	
tendency	for	an	organism’s	genome	to	preferentially	utilize	more	of	one	codon	for	a	particular	
amino	acid.	For	example,	yeast	have	a	tendency	to	use	the	AGA	codon	to	encode	for	arginine	


















is	 under	 spectinomycin	 selection,	 ensuring	 that	 positive	 selection	 via	 antibiotics	 allow	 only	
organisms	 harboring	 all	 three	 plasmids	 to	 survive.	 However,	 under	 this	 system	 there	 was	
extensive	 difficulty	 growing	 both	 MBP	 99	 and	 341	 cultures	 in	 LB	 agar,	 despite	 successful	










smaller	 expressions	 visualized	 on	
SDS-PAGE.	Scaling	up	the	volume	of	
protein	 expression	 did	 help	
overcome	 low	 yield,	 but	 the	
increased	usage	of	scarce	resources	
made	 that	 method	 prohibitively	
expensive	for	the	amount	of	protein	
recovered.	 To	overcome	 this	 issue,	
expression	 cultures	 were	 grown	 in	
SOC	media,	which	 is	more	nutrient	
rich	(MP	Biomedical,	Super	Optimal	












and	 direct	 it	 towards	 synthesizing	 full-length	 protein.	 Gratifyingly,	 results	 indicated	 that	 this	
approach	was	successful.	MBP	341	expressed	under	these	conditions	did	so	predominantly	as	
full-length	protein,	although	MBP	99	tended	largely	towards	the	truncated	form	(Figure	3.4).		
	 Repeated	 attempts	 at	 performing	 click	 reactions	 on	MBP	
341-pAzF	 mutants	 were	 made,	 but	 no	 samples	 exhibited	
fluorescence	when	analyzed	with	SDS-PAGE.	Consequently,	
bioconjugation	 reactions	were	 altered	 to	utilize	Glaser-Hay	





weight	 in	 SDS-PAGE.	 Importantly,	 there	 was	 also	 no	
















As	 the	 amber	 codon	 is	 expressed	 on	 the	MBP	 and	 no	 truncation	 was	 observed,	 this	
mutant	should	be	capable	of	binding	SUMO.	The	size	of	the	Glaser-Hay	reactions	employed	in	
this	process	inevitably	leads	to	a	dilution	of	the	protein	due	to	limitations	in	the	concentrating	
abilities	 of	 the	 columns	 used	 for	 protein	 concentration.	 To	 correct	 for	 this,	 eight	 Glaser-Hay	
bioconjugations	were	 performed	 simultaneously	 on	 samples	 of	MBP	341-pPrF	 and	 combined	
during	the	wash	cycles.	Unfortunately,	the	stock	of	SUMO	beads	were	depleted	by	earlier	pull-















Schultz	and	Kerscher	 labs.	All	unnatural	amino	acids	were	 synthesized	according	 to	 literature	
protocols.	Protein	gels	were	imaged	using	a	Bio	Rad	gel	imager.		
Expression	and	Purification	of	Protein:	An	Eppendorf	eporator	electroporator	was	used	to	co-
transform	 a	 pET	 plasmid	 for	 the	 variable	MBP-Utag	 fusion	mutant	 (0.5	 μL)	 and	 a	 synthetase	






















incubated	at	 room	 temperature	with	 the	 caps	off	 for	4	hours.	 The	 supernatant	was	 carefully	
removed,	avoiding	 the	 insoluble	CuI	 settled	at	 the	bottom,	and	placed	 in	a	molecular	weight	
cutoff	column.	The	reaction	was	then	washed	with	PBS	buffer	(8x	200	μL)	before	being	retrieved	
from	the	column.	Reactions	were	then	imaged	using	SDS-PAGE	(10%).		
CuACC	 Reaction:	 Samples	 were	 first	 buffer	 exchanged	 into	 PBS	 containing	 1mM	 DTT	 using	

























































	 Dehaloperoxidase	 (DHP)	 is	 a	 globin	enzyme	native	 to	 the	Amphitrite	ornata,	 a	marine	
bristle	worm.1	It	is	a	protein	of	significant	interest	due	to	its	unique	ability	to	act	as	a	peroxidase,	
in	addition	to	its	normal	globin	function	as	an	oxygen	transport	mechanism.1	A.	ornata	uses	this	




vulnerable	 environments.	What	makes	DHP	 such	 an	 interesting	 protein	 is	 that	 its	 globin	 and	




hypothesized	 that	 it	 involves	 the	
generation	 of	 tyrosyl	 radicals	 as	
intermediates	 between	 its	
peroxide	 and	 oxygen-binding	
states.3	 Making	 the	 situation	
more	 complex	 is	 the	 fact	 that,	






















	 A.	 ornata	 itself	 does	 not	
produce	 any	 toxic	 halogenated	
organic	metabolites,	but	coexists	in	
an	 environment	 where	 many	Figure	4.7:	DHP’s	basic	oxidation	of	a	trihalophenol	to	a	dihaloquinone
3	
	 44	













as	 faster	 than	Myoglobin	 but	 slower	 than	Horseradish	 Peroxidase.1,3,8	 DHP	 A	 and	DHP	 B	 are	
expressed	from	two	different	genes	in	A.	ornata,	and	while	they	crystalize	as	a	dimer,	they	tend	
to	 exist	 in	 solution	 as	 monomers,	
leading	 to	 some	 confusion	 on	















followed	by	 its	 regeneration	via	two	one-electron	substrate	oxidations.12	The	ferric	 (Fe3+)	and	
ferryl	(Fe4+)	states	are	crucial	for	typical	peroxidase	activity,	whereas	the	oxyferrous	(Fe2+)	state	
that,	 as	 an	 oxygen-carrying	 globin,	 DHP	 finds	 itself	 in	 is	 catalytically	 inactive.	 DHP	 has	 been	
characterized	 as	 performing	 this	 same	 net	 two-electron	 oxidation,	 but	 it	 does	 so	 via	 the	
formation	 of	 a	 one-electron	 oxidized	 heme	 center	




of	 TXP	 and	 the	 begin	 of	 catalytic	 activity,	 other	 researchers	
believe	that	trace	amounts	of	ferric	protein	create	TXP	radicals	
that	then	convert	DHP	to	its	ferric	form.	They	hypothesize	that	




















addition	 to	 its	 typical	 peroxidase	 function.	Where	 peroxidases	 utilize	H2O	 for	 their	 source	 of	
oxygen,	peroxygenases	utilize	H2O2.
11	The	peroxygenase	pathway	(Figure	4.5)	was	first	seen	to	
oxidize	 monohalindoles	 to	 oxindolenines,	 whereupon	 O2	 was	 used	 to	 further	 oxidize	 the	




	 The	 bioremediation	 potential	 of	 DHP	 does	 not	 stop	 at	 the	 oxidation	 of	 halophenols,	





bind	hydrogen	sulfide,	allowing	DHP	 to	oxidize	and	 remove	another	 toxic	 compound	 from	 its	
environment.	This	reinforces	that	this	His55	residue	is	a	versatile	and	important	feature	in	DHP’s	







site	 specific	 mutagenesis,	 and	 computational	 chemistry.7	 Two	 locations	 for	 tyrosyl	 radical	












	 In	 order	 to	 probe	 the	 actual	 mechanism	 of	 tyrosyl	 radical	 assignment,	 the	 unnatural	
amino	acid	3-fluorotyrosine	(3-FY)	will	be	site-specifically	incorporated	to	the	protein.	The	use	of	
this	 UAA	 in	 particular	 has	 several	 benefits,	 such	 as	 minimizing	 the	 structural	 perturbations	
observed	due	to	phenylalanine,	and	allowing	the	normal	radical	pathway	to	proceed	unhindered.	
This	 is	 particularly	useful,	 as	3-FY	has	a	unique	EPR	 signal	 from	 tyrosine,	 allowing	 the	 radical	
formation	 and	 peroxidase	 mechanism	 to	 be	 followed	 more	 closely	 under	 both	 natural	 and	
experimental	conditions.18		





UAA.	 The	 mutant	 was	 analyzed	 via	 UV-Vis	 and	
compared	 to	 DHP	 A-WT	 to	 determine	 its	 purity,	
then	via	SDS-PAGE	in	order	to	determine	that	the	
mutant	was	 expressed	 as	 a	 full	 length	 protein.	 A	
mass	 spectrum	 analysis	 of	 the	mutant	 confirmed	
that	 the	 3-FY	 UAA	 was	 incorporated,	 with	 the	
mutant	being	18.5	m/z	heavier	than	the	wild-type	








difference	 is	only	about	 two-fold.	Similarly,	 the	rate	the	reaction	proceeded	(kcat)	was	slightly	
higher		in	the	DHP	A	Y34Y3F	mutant	than	the	other	DHP	proteins.	As	a	result	the	3FY	mutant’s	
catalytic	 efficiency	 (kcat/Km)	 was	 lower	 than	 the	 other	 proteins,	 and	 while	 the	 difference	 is	
statistically	significant,	it	is	not	enough	to	suggest	that	the	3FY	mutant’s	peroxidase	activity	was	






would	 provide	 a	 way	 to	 more	 deeply	 probe	 the	 DHP’s	 radical	 mechanism.	 Two	 different	
fluorotyrosine	 UAAs	 could	 be	 incorporated	 into	 DHP	 A	 by	 using	 another	 synthetase	 system,	










A	 Y34TAG	 and	 Y38TAG	 mutants	 were	 both	 expressed	 using	 another	 UAA,	 p-
propargyloxyphenylalanine	 (pPrF),	 due	 to	 the	
difficulty	 of	 obtaining	 the	 large	 amounts	 of	
fluorotyrosine	 needed	 during	 this	
troubleshooting	 period.	 No	 mutant	 protein	
obtained	was	of	 the	 correct	molecular	weight	
compared	 to	 DHP	 A	WT,	with	 any	 discernible	
bands	 seen	 via	 SDS-PAGE	 analysis	 existing	 at	
molecular	weights	 about	 twice	 that	 of	 DHP	 A	
WT.	
DHP	A	 Y34TAG	 and	 Y38TAG	have	 been	 challenging	 to	 express	 in	 good	 yield.	 Previous	
research	has	shown	that	 it	 is	possible	to	express	this	protein	using	a	variety	of	 fluorotyrosine	
UAAs,	 particularly	 3-FY	 and	 2,3,6-FY.	 Future	 research	 will	 optimize	 the	 expression	 of	 DHP	 A	
Y34TAG	 and	 Y38TAG	 in	 order	 to	 reliably	 integrate	UAAs	 to	DHP’s	 structure,	 allowing	 for	 the	
investigation	of	DHP’s	radical	mechanism.	Kinetic	values	and	intermediates	of	the	DHP	A	34	and	
38	 mutants	 will	 be	 analyzed	 with	 UV-vis,	 stopped	 flow	 UV-vis,	 and	 rapid	 quench	 EPR	












Eppendorf	 eporator	 electroporator.	 The	 cells	were	 then	 plated	 and	 grown	 on	 LB	 agar	 in	 the	
presence	of	chloramphenicol	(0.034	mg/mL),	ampicillin	(0.050	mg/mL)	at	37	̊	C	overnight.	Two	
colonies	 were	 then	 used	 to	 inoculate	 two	 separate	 aliquots	 of	 LB	 media	 (5	 mL)	 containing	
ampicillin	 and	 chloramphenicol.	 The	 cultures	were	 incubated	 at	 37	̊	 C	 overnight	 and	 used	 to	
inoculate	an	expression	culture	(1.5	L	LB	media,	1.5	mL	50	mg/mL	Amp,	1.5	mL	34	mg/mL	Chlor,	
10	mL	0.01	mg/mL	Hemin)	at	an	OD600	0.1.	The	cultures	were	 incubated	at	37	̊	C	 to	an	OD600	
between	 0.6	 and	 0.8	 at	 600	 nm,	 and	 protein	 expression	 was	 induced	 by	 addition	 of	 3-
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